REPLIGEN CORPORATION

NASDAQ: RGEN (Repligen Corporation)

Kemas kini terakhir: 44 minit lalu

145.18

-1.74 (-1.18%)

Penutupan Terdahulu 146.92
Buka 147.29
Jumlah Dagangan 515,537
Purata Dagangan (3B) 530,250
Modal Pasaran 8,133,956,096
Harga / Pendapatan (P/E Ke hadapan) 90.91
Harga / Jualan (P/S) 12.77
Harga / Buku (P/B) 4.06
Julat 52 Minggu
113.50 (-21%) — 207.87 (43%)
Tarikh Pendapatan 20 Feb 2025
Margin Keuntungan -1.28%
Margin Operasi (TTM) -3.02%
EPS Cair (TTM) -0.030
Pertumbuhan Hasil Suku Tahunan (YOY) 9.70%
Pertumbuhan Pendapatan Suku Tahunan (YOY) -83.40%
Jumlah Hutang/Ekuiti (D/E MRQ) 33.35%
Nisbah Semasa (MRQ) 10.44
Aliran Tunai Operasi (OCF TTM) 165.28 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 138.31 M
Pulangan Atas Aset (ROA TTM) 0.60%
Pulangan Atas Ekuiti (ROE TTM) -0.40%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Instruments & Supplies (US) Bercampur Bercampur
Medical Instruments & Supplies (Global) Bercampur Bercampur
Stok Repligen Corporation Menaik Menurun

AISkor Stockmoo

1.4
Konsensus Penganalisis 3.0
Aktiviti Orang Dalam NA
Volatiliti Harga 2.0
Purata Bergerak Teknikal 1.0
Osilator Teknikal -0.5
Purata 1.38

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
RGEN 8 B - - 4.06
MMSI 6 B - 52.75 4.76
LMAT 2 B 0.64% 55.35 6.70
AZTA 2 B - - 1.22
PLSE 1 B - - 16.32
STAA 819 M - - 1.90

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Sektor Healthcare
Industri Medical Instruments & Supplies
Gaya Pelaburan Small Growth
% Dimiliki oleh Orang Dalam 7.23%
% Dimiliki oleh Institusi 101.96%

Pemilikan

Nama Tarikh Syer Dipegang
Harding Loevner Lp 30 Sep 2024 916,142
375.25375.25304.00304.00232.75232.75161.50161.5090.2590.25Harga Sasaran MedianQ1 '20Q1 '20Q2 '20Q2 '20Q3 '20Q3 '20Q4 '20Q4 '20Q1 '21Q1 '21Q2 '21Q2 '21Q3 '21Q3 '21Q4 '21Q4 '21Q1 '22Q1 '22Q2 '22Q2 '22Q3 '22Q3 '22Q4 '22Q4 '22Q1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25
Julat 52 Minggu
113.50 (-21%) — 207.87 (43%)
Julat Harga Sasaran
165.00 (13%) — 180.00 (23%)
Tinggi 180.00 (HC Wainwright & Co., 23.98%) Beli
Median 172.50 (18.82%)
Rendah 165.00 (Canaccord Genuity, 13.65%) Pegang
Purata 172.50 (18.82%)
Jumlah 1 Beli, 1 Pegang
Harga Purata @ Panggilan 163.02
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
HC Wainwright & Co. 23 Jan 2025 180.00 (23.98%) Beli 167.90
Canaccord Genuity 17 Dec 2024 165.00 (13.65%) Pegang 158.14

Tiada data dalam julat masa ini.

166.50166.50157.97157.97149.43149.43140.90140.90132.36132.36Feb 6Feb 6Feb 7Feb 7Feb 10Feb 10Feb 11Feb 11Feb 12Feb 12Feb 13Feb 13Feb 14Feb 14Feb 18Feb 18

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
4.0004.0002.0002.0000.0000.000-2.000-2.000-4.000-4.000MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda